Why Cettire, Gold Road, Imugene, and Paladin Energy shares are racing higher

These shares are ending the week with a bang. But why? Let's find out.

| More on:
A smiling businessman in the city looks at his phone and punches the air in celebration of good news.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is fighting hard to end the week on a positive note. In afternoon trade, the benchmark index is up 0.4% to 8,232.7 points.

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:

Cettire Ltd (ASX: CTT)

The Cettire share price is up 3.5% to $1.62. This is despite there being no news out of the online luxury products retailer. However, with its shares down over 40% since this time last year and 67% from their 52-week high, it seems that some investors believe that a buying opportunity has been created.

Gold Road Resources Ltd (ASX: GOR)

The Gold Road share price is up almost 3% to $2.12. This follows a decent night of trade for the gold price on Wall Street. According to CNBC, the gold futures price was up over 1% to US$2,668.8 an ounce during overnight trade on safe haven demand. This meant that the precious metal climbed to a two-week high. It isn't just Gold Road Resources that is rising today. The S&P/ASX All Ordinaries Gold index is up 2.5% at the time of writing.

Imugene Ltd (ASX: IMU)

The Imugene share price is up 2.5% to 4 cents. This morning, this immuno-oncology company released an update on its phase 1b clinical trial of its allogeneic CAR T-cell therapy azer-cel at the Royal Prince Alfred Hospital (RPAH) in Sydney. It is focused on patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), which is one of the most challenging and aggressive forms of non-Hodgkin's lymphoma. According to the release, the first Australian patient has been dosed in the Phase 1b clinical trial at the RPAH. Imugene CEO, Leslie Chong, said: "Achieving first patient dosed for azer-cel in Australia represents a significant milestone for Imugene and for Australian patients battling this devastating disease."

Paladin Energy Ltd (ASX: PDN)

The Paladin Energy share price is up 8% to $8.53. A number of ASX 200 uranium stocks are racing higher on Friday after industry giant Cameco announced the suspension of production at its joint venture with Kazatomprom. Cameco stated: "We are disappointed and surprised by this unexpected suspension and we will be seeking further clarification on how this transpired, as well as the potential 2025 and 2026 production and financial impacts (including on future dividends), and what Cameco can do to help Kazatomprom and JV Inkai restart mining operations."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A woman wearing headphones looks delighted and animated on news she's receiving from her mobile phone that she is holding close to her face.
Share Gainers

Why Brainchip, Fortescue, Mesoblast, and QBE shares are racing higher today

These shares are starting the year in a positive fashion. But why?

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Share Gainers

These were the 5 best performing ASX 200 shares in 2024

Let's see why these shares delivered massive returns last year.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

These were the best ASX 200 shares to own in December

Let's see why these shares outperformed the market in December.

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Why DroneShield, Invictus Energy, Mesoblast, Weebit Nano shares are rising today

These shares are on course to end the year on a positive note. But why?

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Brainchip, Imricor, Strike Energy, and Wildcat shares are rising today

Why are these shares starting the week strongly? Let's find out.

Read more »

Emotional euphoric young woman giving high five to male partner, celebrating family achievement, getting bank loan approval, or financial or investing success.
Share Gainers

Why Bowen Coal, Droneshield, Mesoblast, and St Barbara shares are racing higher today

These shares are ending the week positively. But why?

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher

These shares are having a better day than most today. But why?

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why EOS, News Corp, Polynovo, and Pro Medicus shares are roaring higher today

These shares are starting the week positively. But why?

Read more »